Carole Sable

Director/Board Member at BASILEA PHARMACEUTICA AG

Net worth: - $ as of 31/05/2026

64 year

Health Technology

Consumer Services

Profile

Carole A. Sable is currently an Independent Non-Executive Director at Basilea Pharmaceutica AG since 2023.
Former positions include Executive Director-Clinical Research at Merck & Co., Inc. from 1995 to 2007, Vice President at Merck & Co., Inc. from 2010 to 2013, Chief Medical Officer at Vitae Pharmaceuticals LLC in 2016, Assistant Professor at the University of Virginia from 1993 to 1995, Chief Medical Officer at SCYNEXIS, Inc. from 2014 to 2015, Chief Medical Officer at Novexel SA from 2009 to 2010, Head-Clinical Development at Antabio SAS from 2018 to 2021, and Chief Medical Officer at Revolution Medicines, Inc. from 2015 to 2016.
Education includes a doctorate from Thomas Jefferson University, a doctorate from Sidney Kimmel Medical College conferred in 1983, and an undergraduate degree from the University of Scranton.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
BASILEA PHARMACEUTICA AG -.--%	31/12/2025	0 ( -.--% )	- $	31/05/2026

Carole Sable active positions

Companies	Position	Start
BASILEA PHARMACEUTICA AG	Director/Board Member	27/04/2023

All active positions of Carole Sable

Former positions of Carole Sable

Companies	Position	End
Antabio SAS Antabio SAS Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical drugs	Chief Tech/Sci/R&D Officer	01/01/2021
VITAE PHARMACEUTICALS INC	Chief Tech/Sci/R&D Officer	01/11/2016
REVOLUTION MEDICINES, INC.	Chief Tech/Sci/R&D Officer	01/01/2016
SCYNEXIS, INC.	Chief Tech/Sci/R&D Officer	20/02/2015
MERCK & CO., INC.	Corporate Officer/Principal	01/01/2013

See the detail of Carole Sable's experience

Training of Carole Sable

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Carole Sable's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Merck & Co., Inc. Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines	Health Technology
Thomas Jefferson University Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Virginia University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
SCYNEXIS, Inc. SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections	Health Technology
Basilea Pharmaceutica AG Basilea Pharmaceutica AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products	Health Technology
Novexel SA Novexel SA Pharmaceuticals: MajorHealth Technology Researches and develops anti-infective drugs for the treatment of bacterial and fungal infections	Health Technology
University of Scranton University of Scranton Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Vitae Pharmaceuticals LLC Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops small molecule compounds	Health Technology
Sidney Kimmel Medical College Sidney Kimmel Medical College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Antabio SAS Antabio SAS Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical drugs	Health Technology
Revolution Medicines, Inc. Revolution Medicines, Inc. Pharmaceuticals: OtherHealth Technology Develops new therapies derived from natural products	Health Technology